Multimodality neurophysiological testing in the assessment of a novel therapeutic approach to leukodystrophy and Charcot-Marie-Tooth disease

2007 ◽  
Vol 118 (5) ◽  
pp. e165-e166
Author(s):  
C.E.G. Moore ◽  
B.D. Youl ◽  
W.M.H. Moore ◽  
R. Orrell
eLife ◽  
2013 ◽  
Vol 2 ◽  
Author(s):  
Madhumala K Sadanandappa ◽  
Mani Ramaswami

A Drosophila model for a neurological disorder called type 2B Charcot-Marie-Tooth disease reveals that it has its origins in a partial loss of function, rather than a gain of function, which points to the need for a new therapeutic approach.


Sign in / Sign up

Export Citation Format

Share Document